Skip to main content
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Jul;48(7):652–657. doi: 10.1136/jcp.48.7.652

Enzyme immunoassays for IgG and IgM antibodies to Toxoplasma gondii based on enhanced chemiluminescence.

C F Crouch 1
PMCID: PMC502718  PMID: 7560174

Abstract

AIMS--To evaluate the clinical performance of enzyme immunoassays for IgG and IgM antibodies to Toxoplasma gondii based on enhanced chemiluminescence. METHODS--Classification of routine clinical samples from the originating laboratories was compared with that obtained using the chemiluminescence based assays. Resolution of discordant results was achieved by testing in alternative enzyme immunoassays (IgM) or by an independent laboratory using the dye test (IgG). RESULTS--Compared with resolved data, the IgM assay was found to be highly specific (100%) with a cut off selected to give optimal performance with respect to both the early detection of specific IgM and the detection of persistent levels of specific IgM (sensitivity 98%). Compared with resolved data, the IgG assay was shown to have a sensitivity and a specificity of 99.4%. CONCLUSIONS--The Amerlite Toxo IgM assay possesses high levels of sensitivity and specificity. Assay interference due to rheumatoid factor like substances is not a problem. The Amerlite Toxo IgG assay possesses good sensitivity and specificity, but is less sensitive for the detection of seroconversion than methods detecting both IgG and IgM.

Full text

PDF
656

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beattie C. P. The ecology of toxoplasmosis. Ecol Dis. 1982;1(1):13–20. [PubMed] [Google Scholar]
  2. Brooks R. G., McCabe R. E., Remington J. S. Role of serology in the diagnosis of toxoplasmic lymphadenopathy. Rev Infect Dis. 1987 Sep-Oct;9(5):1055–1062. doi: 10.1093/clinids/9.5.1055. [DOI] [PubMed] [Google Scholar]
  3. Daffos F., Forestier F., Capella-Pavlovsky M., Thulliez P., Aufrant C., Valenti D., Cox W. L. Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med. 1988 Feb 4;318(5):271–275. doi: 10.1056/NEJM198802043180502. [DOI] [PubMed] [Google Scholar]
  4. Derouin F., Rabian-Herzog C., Sulahian A. Longitudinal study of the specific humoral and cellular response to Toxoplasma gondii in a patient with acquired toxoplasmosis. J Clin Lab Immunol. 1989 Oct;30(2):97–102. [PubMed] [Google Scholar]
  5. Desmonts G., Couvreur J. Toxoplasmosis in pregnancy and its transmission to the fetus. Bull N Y Acad Med. 1974 Feb;50(2):146–159. [PMC free article] [PubMed] [Google Scholar]
  6. Desmonts G., Remington J. S. Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. J Clin Microbiol. 1980 Jun;11(6):562–568. doi: 10.1128/jcm.11.6.562-568.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Duffy K. T., Wharton P. J., Johnson J. D., New L., Holliman R. E. Assessment of immunoglobulin-M immunosorbent agglutination assay (ISAGA) for detecting toxoplasma specific IgM. J Clin Pathol. 1989 Dec;42(12):1291–1295. doi: 10.1136/jcp.42.12.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Payne R. A., Isaac M., Francis J. M. Enzyme-linked immunosorbent assay (ELISA) using antibody class capture for the detection of antitoxoplasma IgM. J Clin Pathol. 1982 Aug;35(8):892–896. doi: 10.1136/jcp.35.8.892. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Sabin A. B., Feldman H. A. Dyes as Microchemical Indicators of a New Immunity Phenomenon Affecting a Protozoon Parasite (Toxoplasma). Science. 1948 Dec 10;108(2815):660–663. doi: 10.1126/science.108.2815.660. [DOI] [PubMed] [Google Scholar]
  10. Sulzer A. J., Franco E. L., Takafuji E., Benenson M., Walls K. W., Greenup R. L. An oocyst-transmitted outbreak of toxoplasmosis: patterns of immunoglobulin G and M over one year. Am J Trop Med Hyg. 1986 Mar;35(2):290–296. doi: 10.4269/ajtmh.1986.35.290. [DOI] [PubMed] [Google Scholar]
  11. Wilson C. B., Remington J. S., Stagno S., Reynolds D. W. Development of adverse sequelae in children born with subclinical congenital Toxoplasma infection. Pediatrics. 1980 Nov;66(5):767–774. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES